Skip to main navigation
  • Skip to main content
  • Skip to primary sidebar
Imara

Top Navigation

  • Careers
  • Contact Us

Investor Relations

  • Who We Are
    • Management
    • Board of Directors
  • Our Programs
    • IMR-687 & PDE9
    • Posters & Publications
    • Clinical Trials
  • Patients & Families
    • Resources
    • Advocacy Groups
    • Imara Expanded Access Policy
  • Investors
    • Press Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • Contact IR
    • Email Alerts
  • Careers
  • Contact Us

Press Releases

Breadcrumb

Investors » Press Releases

Press Releases

Jan 20, 2021
Imara Announces the Appointment of Kenneth Attie, M.D. as Chief Medical Officer
Jan 06, 2021
Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease

Primary Sidebar

Contact Us

Sign Up for Imara Updates

Footer Social Link

Imara, Inc.
116 Huntington Ave.
6th Floor
Boston, MA 02116
T: 617-206-2020
E: info@imaratx.com

Sign Up for Email Updates
Privacy Policy
Terms of Use
© 2021 Imara, Inc.